Dataset Information


P57Kip2 alterations in adult CFU-E contribute to steroid resistance in Diamond Blackfan anemia

ABSTRACT: Ashley R, Yan H, Wang N, Hale J, Dulmovits BM, Papoin J, Olive ME, Udeshi ND, Carr SA, Vlachosa A, Lipton JM, Da Costa L, Hillyer C, Kinet S, Taylor N, Mohandas N, Narla A, Blanc L. 2019. Despite the effective clinical use of steroids for the treatment of Diamond Blackfan anemia (DBA), the mechanistic bases via which glucocorticoids regulate human erythropoiesis remain poorly understood. Here, we report that the sensitivity of erythroid differentiation to dexamethasone (Dex) is dependent on the developmental origin of human CD34+ progenitor cells, specifically increasing the expansion of CD34+ progenitors from peripheral blood (PB) but not cord blood (CB). Dexamethasone treatment of erythroid-differentiated PB, but not CB, CD34+ progenitors resulted in the expansion of a novel CD34+CD36+CD71hiCD105med immature colony-forming unit-erythroid (CFU-E) population. Furthermore, proteomics analyses revealed the induction of distinct proteins in dexamethasone-treated PB and CB erythroid progenitors. Dexamethasone treatment of PB progenitors resulted in the specific upregulation of p57Kip2, a Cip/Kip cyclin-dependent kinase inhibitor, and we identified this induction as critical; shRNA-mediated downregulation of p57Kip2, but not the related p27Kip1, significantly attenuated the impact of dexamethasone on erythroid differentiation and inhibited the expansion of the immature CFU-E subset. Notably, in the context of DBA, we found that steroid resistance was associated with a dysregulated p57Kip2 expression. Altogether, these data identify a novel glucocorticoid-responsive human erythroid progenitor and provide new insights into glucocorticoid-based therapeutic strategies for the treatment of patients with DBA.

INSTRUMENT(S): Q Exactive Plus

SUBMITTER: Steven A. Carr  

PROVIDER: MSV000084614 | MassIVE | Sat Nov 23 07:22:00 GMT 2019


Similar Datasets

2020-01-01 | S-EPMC7108903 | BioStudies
2018-01-01 | S-EPMC5842122 | BioStudies
2013-01-01 | S-EPMC3602204 | BioStudies
2020-06-12 | S-SUBS10 | BioStudies
1000-01-01 | S-EPMC1895002 | BioStudies
2017-01-01 | S-EPMC5330841 | BioStudies
1000-01-01 | S-EPMC5998938 | BioStudies
2004-01-01 | S-EPMC2172323 | BioStudies
2013-01-01 | S-EPMC3533281 | BioStudies
2012-01-01 | S-EPMC3448262 | BioStudies